dc.creatorMandelcorn Monson, Rochelle
dc.creatorMarrett, Loraine
dc.creatorKricker, Anne
dc.creatorArmstrong, Bruce K.
dc.creatorOrlow, Irene
dc.creatorGoumas, Chris
dc.creatorPaine, Susan
dc.creatorRosso, Stefano
dc.creatorThomas, Nancy
dc.creatorMillikan, Robert C.
dc.creatorPole, Jason D.
dc.creatorCotignola, Javier Hernan
dc.creatorRosen, Cheryl
dc.creatorKanetsky, Peter A.
dc.creatorLee Taylor, Julia
dc.creatorBegg, Colin B.
dc.creatorBerwick, Marianne
dc.date.accessioned2018-12-13T19:46:04Z
dc.date.accessioned2022-10-14T23:37:59Z
dc.date.available2018-12-13T19:46:04Z
dc.date.available2022-10-14T23:37:59Z
dc.date.created2018-12-13T19:46:04Z
dc.date.issued2011-12
dc.identifierMandelcorn Monson, Rochelle; Marrett, Loraine; Kricker, Anne; Armstrong, Bruce K.; Orlow, Irene; et al.; Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma; Elsevier; Cancer Epidemiology; 35; 6; 12-2011; 105-110
dc.identifier1877-7821
dc.identifierhttp://hdl.handle.net/11336/66449
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4320309
dc.description.abstractBackground: Sunlight exposure increases risk of melanoma. Sunlight also potentiates cutaneous synthesis of vitamin D, which can inhibit melanoma cell growth and promote apoptosis. Vitamin D effects are mediated through the vitamin D receptor (VDR). We hypothesized that genetic variation in VDR affects the relationship of sun exposure to risk of a further melanoma in people who have already had one. Methods: We investigated the interaction between VDR polymorphisms and sun exposure in a population-based multinational study comparing 1138 patients with a multiple (second or subsequent) primary melanoma (cases) to 2151 patients with a first primary melanoma (controls); essentially a case-control study of melanoma in a population of melanoma survivors. Sun exposure was assessed using a questionnaire and interview, and was shown to be associated with multiple primary melanoma. VDR was genotyped at the FokI and BsmI loci and the main effects of variants at these loci and their interactions with sun exposure were analyzed. Results: Only the BsmI variant was associated with multiple primary melanoma (OR = 1.27, 95% CI 0.99-1.62 for the homozygous variant genotype). Joint effects analyses showed highest ORs in the high exposure, homozygous variant BsmI genotype category for each sun exposure variable. Stratified analyses showed somewhat higher ORs for the homozygous BsmI variant genotype in people with high sun exposure than with low sun exposure. P values for interaction, however, were high. Conclusion: These results suggest that risk of multiple primary melanoma is increased in people who have the BsmI variant of VDR. © 2011 Elsevier Ltd.
dc.languageeng
dc.publisherElsevier
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S1877782111000580
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/j.canep.2011.03.003
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectBSMI
dc.subjectFOKI
dc.subjectMELANOMA
dc.subjectSUN EXPOSURE
dc.titleSun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución